We are live on ! Find out more
INSM icon

Insmed
INSM

102 hedge funds and large institutions have $538M invested in Insmed in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more call options, than puts

Call options by funds: $4.84M | Put options by funds: $1.96M

43% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 28

1% less funds holding

Funds holding: 103 → 102 (-1)

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

13% less capital invested

Capital invested by funds: $619M → $538M (-$81.2M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
102
Holders Change
-1
Holders Change %
-0.97%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
21
Increased
40
Reduced
28
Closed
22
Calls
$4.84M
Puts
$1.96M
Net Calls
+$2.88M
Net Calls Change
-$3.4M

Top Buyers

1
PAI
Palo Alto Investors
California
+$44.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$28.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$20.1M
4
JHIU
Janus Henderson Investors US
Colorado
+$18.1M
5
RG
Redmile Group
California
+$16.4M

Top Sellers

1
PA
Perceptive Advisors
New York
-$18.1M
2
Franklin Resources
Franklin Resources
California
-$17.3M
3
O
OrbiMed
New York
-$10.8M
4
Millennium Management
Millennium Management
New York
-$7.61M
5
OAM
Oxford Asset Management
United Kingdom
-$7.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCI
51
Columbus Circle Investors
$790K -$898K -59,574 -50%
AllianceBernstein
52
AllianceBernstein
Tennessee
$786K – – –
Goldman Sachs
53
Goldman Sachs
New York
$738K +$770K +51,044 +932%
RFC
54
Russell Frank Company
Washington
$709K -$318K -21,104 -28%
VFA
55
Virtus Fund Advisers
Connecticut
$609K -$45.6K -3,024 -6%
Swiss National Bank
56
Swiss National Bank
Switzerland
$570K +$140K +9,300 +27%
MLICM
57
Metropolitan Life Insurance Company (MetLife)
New York
$513K +$160K +10,579 +37%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$511K +$48.2K +3,195 +9%
NFA
59
Nationwide Fund Advisors
Ohio
$495K +$118K +7,821 +26%
Morgan Stanley
60
Morgan Stanley
New York
$455K -$54.2K -3,592 -9%
AQR Capital Management
61
AQR Capital Management
Connecticut
$406K – – –
TAM
62
Tocqueville Asset Management
New York
$392K +$226K +15,000 +100%
PPA
63
Parametric Portfolio Associates
Washington
$369K -$103K -6,822 -19%
VOYA Investment Management
64
VOYA Investment Management
Georgia
$352K – – –
AIG
65
American International Group
New York
$337K +$1.99K +132 +0.5%
D.E. Shaw & Co
66
D.E. Shaw & Co
New York
$328K -$2.75M -182,051 -88%
State Board of Administration of Florida Retirement System
67
State Board of Administration of Florida Retirement System
Florida
$292K – – –
CS
68
Credit Suisse
Switzerland
$259K -$100K -6,632 -25%
ProShare Advisors
69
ProShare Advisors
Maryland
$257K +$8.01K +531 +3%
NI
70
Numeric Investors
Massachusetts
$221K +$54.3K +3,600 +27%
PP
71
PDT Partners
New York
$215K +$249K +16,504 New
TD Asset Management
72
TD Asset Management
Ontario, Canada
$202K +$234K +15,500 New
Susquehanna International Group
73
Susquehanna International Group
Pennsylvania
$169K -$223K -14,771 -53%
SCA
74
Secor Capital Advisors
New York
$159K +$184K +12,195 New
Jane Street
75
Jane Street
New York
$157K +$181K +12,012 New
1 2
3
4 5

INSM Hedge Fund Activity: Q3 2014 in Review

102 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2014, worth a combined $538M — down 13% from $619M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of INSM and 21 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 40 added.

The largest buyer was Palo Alto Investors, adding an estimated $44.2M. The largest seller was Perceptive Advisors, cutting an estimated $18.1M.

  • 102 institutional investors held Insmed (INSM) as of Q3 2014, down from 103 in Q2 2014.
  • Funds reported $538M of Insmed stock for Q3 2014, down 13% quarter-over-quarter.
  • 21 funds opened new Insmed positions in Q3 2014 and 22 closed out, a net change of -1 holder.
  • The largest Insmed buyer in Q3 2014 was Palo Alto Investors, an estimated $44.2M added.
  • The largest Insmed seller in Q3 2014 was Perceptive Advisors, an estimated $18.1M sold.

Based on aggregated 13F filings for Q3 2014.